5 Conclusion From the perspective of Chinese healthcare payers, our findings suggest that once-daily oral semaglutide as an add-on therapy is likely to be a more cost-effective option than most injectable GLP-1 RAs in China, excluding injectable semaglutide and exenatide, for patients with T2DM who have inadequate control on basal insulin
Frequently asked questions Mounjaro vs Ozempic: Which is right for you
Prices depend on the brand, dosage, and where you get it
Through concierge-level care and integrated treatment plans, we help you tap into your true potential
Visits are completed through a secure platform, allowing a licensed healthcare provider to review health history and determine whether treatment options may be appropriate
Many people also experience long-term improvements in overall health such as increased energy and less fatigue